These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8587371)

  • 21. Effect of BQ-123 and Ro 47-0203 (bosentan) on endothelin-induced vasoconstriction in the rat skin.
    Lawrence E; Brain SD
    Eur J Pharmacol; 1994 Jul; 260(1):103-6. PubMed ID: 7957619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BQ-123, a selective endothelin subtype A-receptor antagonist, lowers blood pressure in different rat models of hypertension.
    Douglas SA; Gellai M; Ezekiel M; Ohlstein EH
    J Hypertens; 1994 May; 12(5):561-7. PubMed ID: 7930556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of BQ-123 on systemic and renal hemodynamic responses to endothelin-1 in the rat split hydronephrotic kidney.
    Cavarape A; Bartoli E
    J Hypertens; 1998 Oct; 16(10):1449-58. PubMed ID: 9814615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of endothelin-induced macromolecular leakage in microvascular beds of rat mesentery.
    Kurose I; Miura S; Fukumura D; Tsuchiya M
    Eur J Pharmacol; 1993 Nov; 250(1):85-94. PubMed ID: 8119327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new endothelin receptor antagonist, TAK-044, shows long-lasting inhibition of both ETA- and ETB-mediated blood pressure responses in rats.
    Ikeda S; Awane Y; Kusumoto K; Wakimasu M; Watanabe T; Fujino M
    J Pharmacol Exp Ther; 1994 Aug; 270(2):728-33. PubMed ID: 8071866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor selectivity of endothelin antagonists and prevention of vasoconstriction and endothelin-induced sudden death.
    Raschack M; Unger L; Riechers H; Klinge D
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S397-9. PubMed ID: 8587425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasoconstrictor effects of endothelin-1 on myocardium microcirculation studied by the Langendorff perfusion method: differential sensitivities among microvessels.
    Homma S; Miyauchi T; Sugishita Y; Goto K; Sato M; Ohshima N
    Microvasc Res; 1992 Mar; 43(2):205-17. PubMed ID: 1584062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of endothelin-1 on arterioles and venules in vivo.
    Fortes ZB; de Nucci G; Garcia-Leme J
    J Cardiovasc Pharmacol; 1989; 13 Suppl 5():S200-1. PubMed ID: 2473310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Demonstration of a vasopressor role of endogenous endothelin after inhibition of nitric oxide synthesis in rats].
    Richard V; Hogie M; Clozel M; Löffler BM; Thuillez C
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1213-6. PubMed ID: 8572876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelin-induced contraction and relaxation of rat isolated basilar artery: effect of BQ-123.
    Feger GI; Schilling L; Ehrenreich H; Wahl M
    J Cereb Blood Flow Metab; 1994 Sep; 14(5):845-52. PubMed ID: 8063879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The peptide endothelin receptor antagonist, TAK-044, produces sustained inhibition of endothelin-1 mediated arteriolar vasoconstriction.
    Ferro CJ; Haynes WG; Johnston NR; Lomax CC; Newby DE; Webb DJ
    Br J Clin Pharmacol; 1997 Oct; 44(4):377-83. PubMed ID: 9354313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelin and prostaglandin H2 enhance arteriolar myogenic tone in hypertension.
    Huang A; Koller A
    Hypertension; 1997 Nov; 30(5):1210-5. PubMed ID: 9369278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelin-1 and vascular tone in subjects with atherogenic risk factors.
    Nohria A; Garrett L; Johnson W; Kinlay S; Ganz P; Creager MA
    Hypertension; 2003 Jul; 42(1):43-8. PubMed ID: 12756218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological characterization of cardiovascular responses induced by endothelin-1 in the perfused rat heart.
    Kusumoto K; Fujiwara A; Ikeda S; Watanabe T; Fujino M
    Eur J Pharmacol; 1996 Jan; 296(1):65-74. PubMed ID: 8720478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the endothelin (ET) receptor antagonist BQ 123 on initial and delayed vascular responses induced by ET-1 in conscious, normotensive rats.
    Bird JE; Waldron TL; Dorso CR; Asaad MM
    J Cardiovasc Pharmacol; 1993 Jul; 22(1):69-73. PubMed ID: 7690099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation.
    Ivy DD; Kinsella JP; Abman SH
    J Clin Invest; 1994 May; 93(5):2141-8. PubMed ID: 8182146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response of isolated intracerebral arterioles to endothelins.
    Edwards R; Trizna W
    Pharmacology; 1990; 41(3):149-52. PubMed ID: 2277808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive effects of the endothelin receptor antagonist BQ-123 in conscious spontaneously hypertensive rats.
    Ohlstein EH; Douglas SA; Ezekiel M; Gellai M
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S321-4. PubMed ID: 7509976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered regulation of endothelin A receptor subtype in the cerebral arterioles in response to a Japanese-style diet, in stroke-prone hypertensive rats.
    Rossi GP; Colonna S; Belloni AS; Savoia C; Albertin G; Nussdorfer GG; Hagiwara H; Rubattu S; Volpe M
    J Hypertens; 2003 Jan; 21(1):105-13. PubMed ID: 12544442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential blockade of the renal vasoconstrictor and diuretic responses to endothelin-1 by endothelin antagonist.
    Kamphuis C; Yates NA; McDougall JG
    Clin Exp Pharmacol Physiol; 1994 Apr; 21(4):329-33. PubMed ID: 7923901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.